Overall, scRNA-seq analysis indicated that Ate-Grab treatment significantly reduced the number of CD141+ CAF-2 cells, a key subset that facilitates tumor fibrosis by promoting collagen production, and enhanced T cell infiltration in the TME in vivo. This evidence concerns the gene THBD and neoplasm.